Drug interactions for the following drug(s)
Applies to: mesalamine 800 MG Delayed Release Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The serum concentration of Valproic acid can be increased when it is combined with Mesalazine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: mesalamine 800 MG Delayed Release Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 833234, name = mesalamine 800 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproic acid, Drug2 is resolved to mesalamine and interaction asserted in DrugBank between Valproic acid and Mesalazine. Drug1 is resolved to valproate, Drug2 is resolved to mesalamine and interaction asserted in DrugBank between Valproic acid and Mesalazine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.